L-Theanine for Cognitive Function

Verdict: Weak, narrow benefit; broad claims unproven

The evidence for L-theanine improving cognitive function is weak. On its own it produces only a small, short-lived speed-up in simple reaction time; the broader "focus and memory" benefits that supplements advertise mostly come from pairing it with caffeine, not from L-theanine alone.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a weak (Tier C) grade because the positive findings are small, acute, and narrow. A 2025 systematic review and meta-analysis (PMID 40314930) found that L-theanine taken alone modestly sped up choice reaction time (SMD -0.35), but most other cognitive gains came from L-theanine combined with caffeine (attention switching SMD 0.33; digit vigilance SMD 0.20). Small crossover trials agree: single doses of 100-200 mg shaved roughly 16 ms off simple reaction time (PMID 36263942) and 400 mg shifted an attention-related brainwave marker (PMID 32777998), yet neither improved sustained attention or self-control.

Crucially, the one longer, real-world test failed. A 12-month trial in older adults with cognitive decline (PMID 39213264) saw no improvement on standard memory and daily-function scores, even though matcha contains both L-theanine and caffeine. Other matcha trials (PMID 39275223) and an athlete study (PMID 37815006) again show benefits tied to the caffeine combination rather than to L-theanine by itself.

Authorities reinforce the caution. The US FDA treats L-theanine as safe (GRAS, 'FDA has no questions') but has approved no cognitive claim, and the EU's EFSA explicitly ruled that 'a cause and effect relationship has not been established' between L-theanine and improved cognition. The Cleveland Clinic likewise notes 'still limited research on the benefits.' Bottom line: do not expect meaningful brain or memory enhancement from L-theanine alone.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
82%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.52
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.477
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Effects of Tea (Camellia sinensis) or its Bioactive Compounds l-Theanine or l-Theanine plus Caffeine on Cognition, Sleep, and Mood in Healthy Participants: A Systematic Review and Meta-Analysis of …
PMID: 40314930 2025 統合分析
Finding: Mono L-theanine vs placebo: Choice reaction time SMD -0.35 (95% CI -0.61, -0.10), small-to-moderate favorable effect. L-theanine+caffeine vs placebo: Digit vigilance accuracy SMD 0.20 (95% CI 0.02, 0.38); Attention switching accuracy SMD 0.33 (95% CI 0.13, 0.54); Choice reaction time SMD -0.48 (95% CI -1.01, 0.05, NS). Conclusion: theanine plus caffeine, AND theanine alone, could be beneficial for cognitive and mood outcomes; combo evidence broader.
🟢 High quality Effect size: [object Object]
View on PubMed
Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study
PMID: 36263942 2023 RCT (double-blind) n = 32
Finding: Mono L-theanine significantly improved simple reaction time at 100 mg (-16.3 ms) and 200 mg (-16.9 ms) vs placebo. NO significant benefit for complex sustained attention or inhibitory control. 400 mg did not outperform lower doses on simple RT.
Effect size: [object Object]
View on PubMed
L-theanine improves neurophysiological measures of attention in a dose-dependent manner: a double-blind, placebo-controlled, crossover study
PMID: 32777998 2022 RCT (double-blind) n = 27
Finding: Mono L-theanine 400 mg significantly reduced parietal P3b latency vs placebo (each 100-mg increase reduced P3b latency by ~4 ms). Lower doses showed no significant ERP changes. No dose-response on P3b amplitude or behavioral reaction time. Suggests dose-dependent enhancement of attentional processing at higher doses (400 mg).
Effect size: [object Object]
View on PubMed
Effect of matcha green tea on cognitive functions and sleep quality in older adults with cognitive decline: A randomized controlled study over 12 months
PMID: 39213264 2024 RCT (double-blind) n = 99
Finding: Primary cognitive outcomes (MoCA, ADCS-ADL) showed NO significant change with matcha vs placebo over 12 months. Secondary: social acuity score (emotional perception) improved (p=0.028); sleep quality trended toward improvement (p=0.088). Population: 64 with subjective cognitive decline + 35 with MCI.
View on PubMed
Matcha Does Not Affect Electroencephalography during Sleep but May Enhance Mental Well-Being: A Randomized Placebo-Controlled Clinical Trial
PMID: 39275223 2024 隨機對照試驗
Finding: Matcha (L-theanine + caffeine combination) did not affect sleep EEG. Mental well-being indicators improved. Direct cognitive performance not primary endpoint.
⚠️ Industry-funded
View on PubMed
Effect of single or combined caffeine and L-Theanine supplementation on shooting and cognitive performance in elite curling athletes
PMID: 37815006 2023 RCT (double-blind)
Finding: Combined caffeine+L-theanine supplementation produced cognitive and performance benefits in elite curling athletes; combination outperformed individual mono interventions on key sport-cognitive metrics. Direct head-to-head supports synergy hypothesis.
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
FDA has no questions source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of L-theanine from Camellia sinensis and improvement of cognitive function source↗
L4d TW TFDA / 衛福部
Neutral
茶氨酸為茶葉中天然存在之胺基酸成分 source↗
L5c Cleveland Clinic
Cautious
still limited research on the benefits source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-l-theanine-001 繁體中文版 →